Norris Medicines informs about outcome of board meeting

14 Feb 2025 Evaluate
Norris Medicines has informed that the Board of Directors at their Meeting held today, Thursday, 13th February, 2025 considered and approved the Un-audited Financial Results along with Limited Review Report for the quarter and nine months ended 31st December, 2024. A copy of the Un-audited Financial Results along with the Limited Review Report of the Auditors thereon issued in this regard is attached as Annexure I .

The above information is a part of company’s filings submitted to BSE.

Norris Medicines Share Price

15.00 0.33 (2.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×